CMR Surgical - Company Research Report
Company Overview
- Name: CMR Surgical Limited
- Mission: To transform surgery with Versius, a next-generation surgical robot, making robotic minimal access surgery universally accessible and affordable.
- Founded: 2014
- Founders: Not specified in the data.
- Key People:
- Massimiliano Colella, Chief Executive Officer
- Andre Nel, Chief Financial Officer
- Mark Slack, Chief Medical Officer
- Sushobhan Dasgupta, President of International Markets
- Susan Firbank, Chief People Officer
- Luke Hares, Chief Technology Officer
- Lionel Gousset, General Manager – Operations
- Michelle Paknad, President of Global Marketing & US Market Entry
- Markus Bauman, Chief Legal & Business Affairs Officer
- Daniel Moore, Non-Executive Chairman
- Headquarters: Cambridge, United Kingdom
- Number of Employees: Not specified in the data.
- Revenue: No information is available.
- What the Company is Known For: Developing and commercializing Versius, a next-generation surgical robot designed for minimal access surgery.
Products
Versius Surgical System
- Description: Versius is a Robotic-Assisted Surgical Device engineered for versatility and adaptability, driven by a digital ecosystem. It is designed to biomimic the human arm and is aimed at empowering hospitals and surgeons to transform surgery. The system is indicated for adult patients 22 years of age and older in the U.S. for soft tissue minimal access surgery, specifically cholecystectomy.
- Key Features:
- Small, modular, and portable design optimized for any operating room.
- Ability to biomimic the human arm for dexterity, precision, and accuracy with small fully-wristed instruments.
- Provides 3D HD vision and 710° range of motion.
- Seamless integration with existing workflows in healthcare settings.
- Supports a comprehensive training pathway via Versius Trainer, Virtual Reality, and an online learning platform.
- Designed for easy adoption with familiarity in port placement aiding rapid proficiency in surgical robotics.
- Captures meaningful data to support ongoing surgical learning through a wider digital ecosystem.
Recent Developments
- FDA Marketing Authorization: On October 14, 2024, CMR Surgical received U.S. FDA marketing authorization for the Versius Surgical System to be used for cholecystectomy. This is a significant milestone for the company, marking the entry of Versius into the U.S. healthcare market.
- Executive Appointments:
- Markus Bauman was appointed as the Chief Legal & Business Affairs Officer on September 3, 2024.
- Michelle Paknad joined as Senior Vice President, Global Business Development for commercial expansion.
- Daniel Moore was appointed as the Non-Executive Chairman on July 15, 2024.
- Massimiliano Colella was appointed Chief Executive Officer on January 14, 2025.
- System Utilization: Versius is the second most utilized surgical robotic system globally, with over 26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East, and Africa.
- Technological Innovations: Versius is digitally driven with software updates provided to ensure the latest technology is available to users. The system includes digital apps and a global metrics-based training program to support surgical proficiency and efficiency in robotic programs.
- Partnerships: CMR plans to partner with a select number of U.S. hospitals to introduce Versius to the U.S. market with an ultimate goal of expanding its presence across the country.
Implementing a strategic multi-stage entry plan ensures CMR secures a strong position in the U.S. market, focusing on enhancing hospital capabilities to perform robotic-assisted surgery more flexibly.
This information-rich report is tailored using available data and eschews external commentary or assumptions where information is unavailable.
